John W. Campbell

Senior Counsel | San Francisco


Represented mezzanine lender and private equity investor in more than 15 financing transactions conducted by specialty pharmaceutical, drug development and medical device companies and several initial and follow-on public offerings by these companies.

Represented leading Japanese pharma company in its acquisition of Agensys Inc., and major investment and collaboration transaction with FibroGen.

Represented genomics technology company from formation in public and private securities offerings and off-shore based research and development financing structures.

Represented leading global container freight leasing company in initial public offering, follow-on offerings, securitized debt financings, and acquisitions.

Represented leading MEMs company from formation, through several rounds of venture financing, initial public offering and follow-on public offerings, 144A convertible debt financing and acquisitions.

Advised educational technology company in securities offerings and other financings, including management of disposition of controlling share blocks, and sale to Vtech Holdings.

Represented leading developer of social media advertising management and monetization software, in formation, several rounds of venture financing, acquisitions and and collaboration with ClearChannel Communications.

Represented leading temporary staffing company in acquisitions, sale of control position to private equity firm, and sale to Select Staffing.

Represented family held real estate and operating company, in sale of Century Theatres to Madison Dearborn and Cinemark and subsequent initial public offering and follow-on offerings by Cinemark.

Represented gene therapy company from formation through preferred stock financings, including strategic financing with Sun Pharmaceuticals, initial and follow on public offerings and PIPE transactions.

Recommended as a Leading Lawyer

Best Lawyers In America 2007–2019